Old Web
English
Sign In
Acemap
>
authorDetail
>
Samrat Khanal
Samrat Khanal
Ipilimumab
Nivolumab
Oncology
Cancer
Internal medicine
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
2019
Therapeutics and Clinical Risk Management
Shi Zhou
Samrat Khanal
Haijun Zhang
Show All
Source
Cite
Save
Citations (15)
1